CS logo
small CS logo
Philippine Heart Center

Quezon City, Philippines
Hospital in Quezon City
J2VX+J72, East Ave, Diliman, Quezon City, Metro Manila

About Philippine Heart Center


The Philippine Heart Center is a hospital in Central, Quezon City, Philippines, specializing in the treatment of heart ailments. It was established in 1975.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Actelion
3
Boehringer Ingelheim
1
Pfizer
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Population Health Research Institute
1
Total Rows: 5

Clinical Trials at Philippine Heart Center


During the past decade, Philippine Heart Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111000000001100111111000000Started TrialsCompleted Trails201620172018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
2008-04-08
2010-05-25
Terminated
130
Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos
2011-12-01
2014-05-01
Completed
3,006
Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
2013-09-10
2018-01-12
Terminated
217
Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
2013-05-21
2016-12-01
Completed
226
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
2016-08-22
2022-08-18
Completed
4,565
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
2017-10-24
2024-02-29
Recruiting
300
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
2022-01-11
2023-07-04
Active, not recruiting
714

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Philippine Heart Center" #1 sponsor was "Actelion" with 3 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Philippine Heart Center" #1 collaborator was "Bayer" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsActelion: 3Actelion: 3Boehringer Ingelheim: 1Boehringer Ingelheim: 1Pfizer: 1Pfizer: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Population HealthResearch Institute: 1Population HealthResearch Institute: 1

Created with Highcharts 11.1.0Top CollaboratorsBayer: 1Bayer: 1University of Cape Town: 1University of Cape Town: 1

Clinical Trials Conditions at Philippine Heart Center


According to Clinical.Site data, the most researched conditions in "Philippine Heart Center" are "Pulmonary Arterial Hypertension" (4 trials), "Kidney Disease, Chronic" (1 trials), "Pneumococcal Disease" (1 trials) and "Rheumatic Heart Disease" (1 trials). Many other conditions were trialed in "Philippine Heart Center" in a lesser frequency.

Clinical Trials Intervention Types at Philippine Heart Center


Most popular intervention types in "Philippine Heart Center" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "BI 690517" (1 trials), "Empagliflozin" (1 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials) and "Macitentan 10 mg tablet, once daily." (1 trials). Other intervention names were less common.

Clinical Trials Genders at Philippine Heart Center


The vast majority of trials in "Philippine Heart Center" are 7 trials for "All" genders.

Clinical Trials Status at Philippine Heart Center


Currently, there are NaN active trials in "Philippine Heart Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Philippine Heart Center, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Philippine Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Terminated: 2Terminated: 2Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1